This article is part of a series of contributions produced with ELMO (European Lifestyle Medicine Organization).

Globally, obesity has more than doubled since 1990, and today more than one in eight people suffer from it. Type 2 diabetes affects over half a billion adults, a figure expected to rise in the coming decades. Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most widespread chronic liver condition worldwide, estimated to affect between a quarter and a third of adults. Metabolic syndrome now affects a sizable portion of the adult population in most middle- to high-income countries. People tend to interpret these phenomena as separate epidemics. It is more accurate to regard them as different manifestations of the same underlying problem: a metabolism overwhelmed by the way we eat, move, sleep, and live.

Over the past fifty years, medicine has confronted this challenge with pharmacotherapy, and the results have been tangible. Statins, antihypertensives, glucose-lowering drugs, and, more recently, incretin-based therapies have improved prognosis and quality of life for millions of people. These treatments, however, tend to address the physiopathological consequences of metabolic diseases rather than their roots. A pill can lower a blood parameter without changing the lifestyle that produced that value. Adherence to therapy declines, costs rise, side effects are felt, and the underlying causes of the disease often remain unchanged.

This is where Lifestyle Medicine finds its place. It is a clinical discipline, grounded in scientific evidence, that uses lifestyle interventions (including nutrition, physical activity, adequate sleep, stress management, avoidance of harmful substances, and healthy social relationships) to prevent, treat, and, in many cases, induce remission of certain chronic diseases. It does not oppose pharmacotherapy, but integrates it into a broader strategy aimed at addressing root causes. And within that strategy, no pillar is more important for metabolic health than nutrition.

To use food as a therapeutic tool, we must first change how we think about nourishment. Food is not merely fuel, nor simply a quantity of energy to be counted in and out. Every meal is a set of biological signals. Nutrients and bioactive compounds modulate gene expression, influence the gut microbiome, modulate inflammation, affect hormone rhythms, and signal to the body whether to store energy or burn it. Seen this way, food becomes one of the most powerful therapeutic interventions a person can undergo, and also the most frequent, because it is consumed multiple times a day, every day, for life. The question is never whether food acts on metabolism, because it always does. The question is whether it is used consciously.

The quality of food matters more than its caloric content

For decades, the dominant view was “arithmetical.” One calorie was a calorie, and weight loss hinged on the balance of energy in versus energy out. That view is incomplete, because calories from different foods behave very differently inside the human body. Energy delivered as fiber-rich legumes, vegetables, and whole grains is absorbed more slowly, blunts spikes in blood sugar, nourishes the gut microbiota, and promotes a greater sense of fullness. The same number of calories from refined starches and sugars is absorbed more quickly, triggers a more pronounced insulin response, and can encourage a faster return of hunger. Two foods that are “identical” on the label can send very different metabolic signals to the body. An food’s impact on our hormones and metabolism depends on its nutritional density, fiber content, glycemic impact, and degree of processing—factors not captured by a simple calorie count.

Ultra-processed foods push metabolism in the least favorable direction for metabolic health

One of the most solid findings of modern nutrition science is that the degree of food processing can influence health independently of the nutrient composition. Ultra-processed foods (UPFs) now account for more than half of the calories consumed in many countries. Many of these products are engineered to be particularly palatable, convenient, and easy to ingest, traits that can promote overeating.

In a randomized controlled trial conducted at the U.S. National Institutes of Health, participants assigned to a diet based on ultra-processed foods consumed about 500 kcal more per day and gained weight compared with the same participants following a minimally processed-food diet, with the same intake of sugars, fats, and fiber.

It was a small study, enrolling 20 adults for a short period, so results should be interpreted with caution and confirmed by longer trials. Yet it stands as the strongest available scientific evidence that the degree of food processing can influence energy intake. The results align with numerous observational studies linking high UPF consumption with higher risks of obesity, type 2 diabetes, cardiovascular disease, and premature death. The reasons remain under investigation. Lower fiber and bioactive compound content, reduced satiety, potential alterations to the intestinal barrier, and the rapid consumption and digestion of these foods are all plausible mechanisms.

The gut microbiome is central

The trillions of bacteria living in the gut are not mere passengers. They act as an additional metabolic organ. When dietary fiber is consumed, digestive enzymes cannot fully break it down, but bacteria can ferment it into short-chain fatty acids like butyrate. These molecules are the primary energy source for the colon’s lining cells, help maintain the intestinal barrier, contribute to modulating inflammation, and improve insulin sensitivity. A diet rich in a wide variety of plant fibers tends to foster a diverse and resilient microbial community that benefits the host. A diet dominated by ultra-processed foods and low in fiber produces the opposite effect, reducing diversity, compromising barrier integrity, and promoting a state of chronic, low-grade inflammation—an inflammation now thought to contribute to insulin resistance and many metabolic diseases. It is one of the clearest pictures of the idea that food is “information.” What ends up on the plate literally shapes the microbial ecosystem that helps regulate metabolism.

Count the dietary pattern, not the single food

Perhaps the most useful insight for daily clinical practice is that metabolic health responds more to overall dietary pattern than to the consumption of a single nutrient or a so-called “superfood.” The most solidly evidence-based patterns, chief among them the Mediterranean diet, together with other whole-foods, plant-centered approaches, share a common framework. They rely primarily on vegetables, fruits, legumes, whole grains, nuts and seeds. They include healthy fats such as olive oil. They advocate limited red and processed meats and are low in refined sugars and ultra-processed foods. The PREDIMED study, among others, showed that following this dietary pattern can significantly reduce cardiovascular events and improve glycemic control in people at high cardiovascular risk. The key element is the overall dietary pattern, not the occasional single food, but the metabolic message the body receives consistently through repeated food choices over time.

Nutrition: an integrated approach to health

Nutrition matters, but it never acts in isolation. One of the most important lessons of Lifestyle Medicine is that the pillars of health are intertwined, and what happens with food is shaped by lifestyle.

Let’s consider sleep. A substantial reduction in sleep can alter the hormones that regulate appetite. Leptin, which signals fullness, decreases, while ghrelin, which signals hunger, increases. The following day, there is increased appetite, a stronger craving for energy-dense and easily consumed foods, and more challenging glycemic control. Chronic sleep deprivation means you’re fighting your physiology every time you try to eat healthily. No dieting plan can fully compensate for this, because lack of sleep modifies the very neuroendocrine signals that guide eating.

The same goes for stress. Persistent psychological stress raises cortisol, promotes visceral fat accumulation, perturbs glycemic regulation, and fosters comfort-driven eating rather than eating in response to true hunger. For many patients, the path to better nutrition runs through improved stress management; without addressing it, dietary advice continues to collide with the biology of a nervous system that is perpetually on alert.

Physical activity also plays a role here. It improves insulin sensitivity, helping muscles absorb glucose from the bloodstream more efficiently, which in turn amplifies the positive effects of the diet. Food and exercise do not operate as two separate levers; they act synergistically, each enhancing the effect of the other.

Once these connections are clarified, the goal of every intervention shifts. It ceases to be an isolated “perfect diet” and becomes a sustainable lifestyle change supported by these pillars. That is why Lifestyle Medicine places so much emphasis on patient-centered care and long-term adherence rather than short bursts of restriction. Restrictive diets are temporary by definition. Weight and old habits often return as soon as a diet ends. What lasts is achieved through realistic, gradual adjustments that a person can maintain, by prioritizing sleep, stress management, and physical activity that make healthy eating feasible.

The concept is simple and transformative. Lifestyle Medicine addresses the major determinants of chronic diseases, not only their biochemical consequences. A glucose-lowering medication improves metabolic control and, in many cases, outcomes, but it does not change the behaviors that led to the disease. A lasting change in eating, sleep, stress, and physical activity, on the other hand, targets the root causes of metabolic disruption, answering the question of why glucose was high before there was a need to treat it.

Clinical assessment: the ABCD approach

If the aim is to address root causes, a patient visit must be structured to identify them. A practical, memorable framework is the ABCD approach: Anthropometric, Biochemical, Clinical, and Dietary or Lifestyle assessment. Taken together, these four aspects allow for a comprehensive portrait of the person, rather than a simple diagnosis.

A) Anthropometric assessment. It includes body mass index (BMI), but there is value in looking beyond that. Waist circumference, waist-to-height ratio, and indicators of body composition and visceral fat often tell a clinically more meaningful story than weight alone. The reason is biological. Visceral fat around internal organs is metabolically active and pro-inflammatory, releasing cytokines and free fatty acids that promote insulin resistance. Two people with the same BMI can have very different risk profiles depending on where they store fat, and measuring waist circumference alongside body weight highlights this metabolic risk.

B) Biochemical assessment. Laboratory markers translate metabolic function into something measurable. Fasting glucose, hemoglobin A1c (HbA1c), a full lipid panel, liver enzymes, and certain inflammatory markers reveal the extent of metabolic disruption and the areas that require greater attention. A high HbA1c indicates elevated blood glucose over a period of time. Elevated liver enzymes can signal fatty liver disease, though they are not specific. A poor lipid profile indicates cardiovascular risk. These same markers eventually become the tools we use to monitor the effectiveness of interventions.

C) Clinical assessment. Here we gather a complete medical history: prior illnesses, current medications, blood pressure, sleep quality, gastrointestinal symptoms, as well as mental and emotional health. It is here that multimorbidity—the co-existence of multiple metabolic-related conditions—emerges: a patient whose poor glycemic control sits alongside hypertension, sleep disorders, mood issues, and joint pain. Metabolic diseases rarely present in isolation, and recognizing this overall picture is essential for an effective treatment plan.

D) Dietary and lifestyle assessment. Finally, at the center of the Lifestyle Medicine consult, we explore how the patient lives. What does their diet look like? How many ultra-processed foods do they consume? When do they eat? How physically active are they? How stressed are they? How is their sleep? Do they use alcohol or tobacco? What social and economic factors influence all of this? This is usually where many of the contributing factors lie.

The core point of the ABCD is that Lifestyle Medicine evaluation examines behavior, environment, and context—not just the disease. It does not simply ask what is wrong; it tries to understand how the person arrived at this situation and what in that person’s life can be realistically and sustainably changed.

Challenges and limitations

It would be dishonest and unfair to patients to present all of this without acknowledging how difficult it can be in reality. Lasting behavior change is truly hard to achieve and sustain. Adherence to lifestyle interventions must withstand the temptations of old habits and an environment that often encourages unhealthy choices. Ultra-processed foods are inexpensive, convenient, aggressively marketed, and widely available. In health care, brief appointments make it hard to offer the ongoing support that behavior change genuinely needs. Moreover, patients must navigate a landscape flooded with nutrition misinformation, where scientific evidence competes with trends and marketing.

It is a question of equity as much as realism. Lifestyle Medicine does not rely solely on personal responsibility. Structural, cultural, and environmental forces heavily shape health-related behaviors, and any honest approach must engage with these realities rather than placing full responsibility on individuals. When applied correctly, Lifestyle Medicine goes beyond the exam room and promotes interventions that involve food environments, public health policies, and community. At the same time, it recognizes that every patient starts from a different baseline and tailors interventions to what they can realistically achieve.

From the October 2026 issue of Integrated Medicine